Our store location is now open with huge sales on RUO products. Monday, Wednesday and Friday 11 a.m. to 6 p.m., Saturday 11 a.m. to 4 p.m.
Marvel Peptide USA
KLOW (BPC + GHK-Cu + TB500 + KPV)
KLOW

KLOW (BPC + GHK-Cu + TB500 + KPV)

Supplied as a lyophilized powder in a sealed vial, for laboratory research use only.

$65.00 per vial

Strengths and prices

StrengthPrice per vial AvailabilityBatch
80 mg $65.00 In stock BGK-2607-0067

Every vial carries its batch code and a QR that opens the certificate of analysis for that exact batch. No account is needed to read one.

What it is

A blend of four components in one vial: BPC-157, the copper peptide GHK-Cu, TB-500 (thymosin beta-4) and the tripeptide KPV.

Identity

TypeBlend of four peptides
ComponentsBPC-157, GHK-Cu, TB-500 (thymosin beta-4) and KPV
AmountsAs stated on the label and the certificate of analysis

A blend of four components lyophilized together in one vial. BPC-157 is the pentadecapeptide Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, C62H98N16O22, 1419.5 g/mol (PubChem CID 9941957). GHK-Cu is the copper(II) complex of glycyl-histidyl-lysine; the peptide alone is C14H24N6O4, 340.38 g/mol, and the complex about 403 g/mol (PubChem CID 71587328). TB-500 is thymosin beta-4, a 43-amino-acid N-acetylated peptide, C212H350N56O78S, 4963 g/mol (PubChem CID 45382195); the name is also used for a 7-residue fragment, and the mass on the certificate shows which a batch contains. KPV is the tripeptide Lys-Pro-Val, C16H30N4O4, 342.43 g/mol (PubChem CID 125672). The vial holds 80 mg in total, and the copper of GHK-Cu typically gives the powder a blue tint. It is supplied as a lyophilized powder in a sealed vial.

What the published research covers

The published literature covers the components one at a time. Studies of this combination as a single preparation are few or absent.

KLOW combines four compounds that have separate literatures. BPC-157 is a 15-amino-acid fragment of a gastric protein, studied since the early 1990s mainly in rats by one group in Zagreb; a representative study reported faster healing of a transected Achilles tendon (Staresinic, 2003). GHK-Cu is the copper complex of a tripeptide isolated from human plasma; in cultured human fibroblasts it stimulated collagen synthesis, with the largest effect at a nanomolar concentration (Maquart, 1988). TB-500 is a trade name for thymosin beta-4, a 43-amino-acid actin-binding peptide; in rats with full-thickness skin wounds it increased re-epithelialization (Malinda, 1999).

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone. In cultured human intestinal epithelial cells and T cells it was taken up by the peptide transporter PepT1 and inhibited NF-kappaB signaling at nanomolar concentrations, and given in drinking water it reduced chemically induced colitis in mice (Dalmasso, 2008); a German group reported similar results in two mouse colitis models (Kannengiesser, 2008). The four components therefore come from different lines of research: tissue repair in rats for BPC-157 and thymosin beta-4, cell culture and cosmetic chemistry for GHK-Cu, and intestinal inflammation in mice for KPV.

No study of the four together has been published, and PubMed lists no experimental study pairing KPV with any of the other three. The only published combination study of two of the components, BPC-157 with TB-500 after Achilles tendon repair in rats, reported that the pair conferred no additional benefit compared with either peptide alone (Bicer, 2026). Nothing has been published on whether the components interact chemically when lyophilized together, for instance whether copper from GHK-Cu exchanges onto the other peptides. The certificate of analysis, which confirms each component by mass spectrometry, is the only document that speaks to a given batch, and there are no human data on the combination.

Regulatory status

Not approved by the FDA for any use. Supplied for laboratory research only.

Testing and documentation

A blend is tested for each component: mass spectrometry confirms that every peptide named on the label is present, and HPLC reports the purity. The certificate of analysis for the batch is reachable from the code on the vial.

Questions laboratories ask

What is in a vial of KLOW?
Four components: BPC-157, the copper peptide GHK-Cu, TB-500 (thymosin beta-4) and the tripeptide KPV, 80 mg in total per vial, as listed on the product page. The label and the certificate of analysis for the batch state the amount of each.
Has this combination been studied?
No study of these four components together has been published. Each has its own literature, mostly in cell culture and rodents, and one rat study has examined two of them, BPC-157 and TB-500, together.
How is a blend tested?
By an independent laboratory, for each component: mass spectrometry confirms that all four components named on the label are present, and HPLC reports the purity. The QR code on the vial opens the certificate for that exact batch.
Who can order, and how does it ship?
Orders are accepted under the Research Use Agreement, reaffirmed with every order. Orders ship from Montana, the next business day when paid by card, to United States addresses only and not to freight forwarders.

References

  1. Maquart FX et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. PubMed 3169264
  2. Malinda KM et al. (1999). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology. PubMed 10469335
  3. Staresinic M et al. (2003). Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research. PubMed 14554208
  4. Dalmasso G et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. PubMed 18061177
  5. Kannengiesser K et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. PubMed 18092346
  6. Bicer O et al. (2026). Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Joint Diseases and Related Surgery. PubMed 42542926

How it ships

Next day
Dispatched from Montana on all orders, packed and tracked.
One vial
The minimum order. You pay by card at checkout, or by invoice before the order ships.
Your batch
The certificate of analysis for the batch you receive is on the vial and on this site.

Ordering

Ordering needs an account. A retail account opens as soon as you request it and costs nothing. You pay by card at checkout, or by invoice before the order ships. A wholesale account is reviewed before it opens.

Research use only

This product is a research chemical sold solely for in-vitro laboratory research by qualified persons. It is not a drug, food, supplement or cosmetic, has not been evaluated by the FDA, and must not be administered to any person or animal. Read the full agreement

More from the catalog

All peptides, strengths and prices →